Last updated on June 2017

A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis


Brief description of study

A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis

Detailed Study Description

This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.

Clinical Study Identifier: TX150172

Contact Investigators or Research Sites near you

Start Over

Coastal Carolina Research Center

Coastal Carolina Research Center
Mount Pleasant, SC USA
  Connect »